Catalyst Wire Dossier Catalyst Wire Dossier

Vebectotamab Vedotin

vebetotamab vedotin
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vebectotamab Vedotin, covering 2026-04-20 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: Vebectotamab Vedotin Combined With Pucotelimab in the Treatment of Locally Advanced Laryngeal Carcinoma [Phase 1, Phase 2]

See pricing